MBCINDA@EC2612A

Green Leaf Pharma Injects 285 Million Yuan into Nanjing Greenleaf

China Cinda Shenzhen Branch to Auction Shenzhen Wanhong Logistics' Debt Package on Alibaba Platform

Yibin Kayi Auto Adds Shareholder, Increases Registered Capital to Approximately 600 Million Yuan

Cinda Asset Management holds extraordinary general meeting to approve charter revisions and abolish supervisory board

Harbin Bank Signs Loan Transfer Agreement with China Cinda to Optimize Asset Structure

Intense Competition for Shanshan Group's Restructuring Investor Involving Multiple Major Enterprises

E Fund Management Co. Increases Stake in Cinda

China Cinda Participates in the Merger of CICC and Cinda Securities

China Cinda Wholly Establishes Wuhu Xinsu Equity Investment Co., Ltd.

HKEX Discloses HK Connect and Shenzhen Connect Holding Records, China Cinda Holdings Gains the Most in Shareholding

Wuhu Xinxin Smart Creation Management Partnership Fund Established by China Cinda and Other Investors

HK Stock Connect Holding Changes: China Cinda Most Increased, Ganfeng Lithium Holding Ratio Up Most

Cinda Fujian Subsidiary Plans to Publicly Transfer a Package of Claim Assets

Cinda Xinyue Launches Urban Renewal Project for Shanghai Cinda Tower

S&P Confirms Stable Outlook for China Cinda and China Orient

Cinda China Full Redemption of 8 Billion RMB Tier 2 Capital Bonds

Pteron Times Adds Shareholder Linked to China Cinda

Cinda Securities Discusses Potential Merger with CICC and Orient Securities

China Cinda plans to 减持 Fangzheng Securities 1% shares

Cinda Hong Kong Successfully Issued 2Billion Yuan 5-Year Renminbi Bonds

KO YO GROUP

GEOTECH HLDGS

CHINA INFO TECH

REDCO HEALTHY

AGTECH HOLDINGS

CH CITY INFRA

RMH HOLDINGS

MATRIX HOLDINGS

SOFTMEDX

PUTIAN COMM

159837

520880

159992

159316

510660

02186

520690

513700

Luye Pharma Group has announced a RMB285 million capital injection into its subsidiary, Nanjing Luye, through a structured deal involving Nanjing Xinan and Ningbo Cinda. This investment will leave Luye Pharma with a 70.01% stake in the subsidiary. The deal includes equity option agreements allowing Luye’s affiliate to buy out new investors' stakes. This transaction is classified as a deemed partial disposal under Hong Kong listing rules, highlighting Luye's flexible financing strategy while maintaining control over its Nanjing operations. The current analyst rating for Luye Pharma stock is a Hold with a price target of HK$3.00.

Tip Ranks

E Fund CSI Biotechnology Theme ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Yinhua CSI Innovative Drugs Industry ETF

E Fund Hang Seng SCHK Innovative Drug ETF

ChinaAMC SSE Health Care ETF Initiating Fund

LUYE PHARMA

Bosera Hang Seng SCHK Innovative Drug Select ETF

Penghua CSI HK Connect Health Care Composite ETF

Luye Pharma Injects RMB285 Million into Nanjing Unit via Structured Deal

00111

Cinda International Holdings Limited anticipates a net profit of HK$74 to 82 million for the year ending December 31, 2025, a significant rise from HK$10.34 million in 2024. This increase is mainly due to the reversal of impairment loss on a financial asset and gains from the appreciation of the Renminbi against the Hong Kong dollar. The audited results will be published in March 2026.

Reuters

CINDA INTL HLDG

Cinda International Expects 2025 Net Profit to Surge to HK$74–82 Million

00859

Zhongchang International Holdings Group Ltd. has announced the resignation of Ms. Huang Zhenghong as executive director, effective January 23, 2026. Mr. Wu Hao will take over the role on the same date.

ZHONGCHANG INTL

Zhongchang International Appoints Wu Hao as Executive Director

01359

600657

601059

China Cinda Asset Management Co. Ltd. held its first extraordinary shareholders’ meeting of 2026 on January 21, where proposals for the election of Wang Changyun, Sun Maosong, and Wang Pengcheng as independent non-executive directors were approved. This information was published via the Issuer Information Service of the Hong Kong Stock Exchange.

CHINA CINDA

Cinda Real Estate

Cinda Securities

China Cinda Asset Management Co. Ltd. held extraordinary shareholders' meeting

601611

CNEC: CHINA CINDA will reduce its holdings of the company's shares by 7.8666 million shares through centralized bidding from January 7, 2026, to January 9, 2026, accounting for approximately 0.26% of the total shares of the company

Wallstreetcn

CNEC

Huscoke Holdings Limited has secured a two-year extension of a HK$200 million facility with China Cinda (HK) Asset Management. The facility, now secured with new collateral, will have a reduced interest rate of 5%-8% per annum. This arrangement aims to stabilize Huscoke's liquidity and capital structure while addressing a pending winding-up petition in the Hong Kong High Court. Huscoke operates in the energy sector through subsidiaries in mainland China.

Huscoke Secures Two-Year Extension of HK$200 Million Cinda Facility with New Collateral

China Cinda Asset Management Co. Ltd. has appointed Mr. Song Weigang as executive director and president. The board now includes Zhang Weidong, Song Weigang, and Zhao Limin as executive directors, Zeng Tianming and Zhang Zhongmin as non-executive directors, and Lu Zhengfei, Lam Chi Kuen, Wang Changyun, Sun Maosong, and Shi Cuijun as independent non-executive directors. This announcement was published via the Issuer Information Service of the Hong Kong Stock Exchange.

China Cinda Appoints Song Weigang as Director and President

China Cinda Asset Management Co. has updated its Nomination and Remuneration Committee's terms of reference to enhance corporate governance. The committee, primarily composed of independent directors, will standardize the selection, evaluation, and compensation of directors and senior management, ensuring compliance with Hong Kong regulations. The latest analyst rating for China Cinda's stock (HK:1359) is a Hold, with a price target of HK$1.50. The company, focused on asset management and distressed asset resolution, has a market cap of HK$50.38B.

China Cinda Tightens Governance With New Nomination and Remuneration Committee Mandate

China Cinda Asset Management Co. Ltd. has submitted an updated director list to the Hong Kong Stock Exchange. The Board is chaired by Executive Directors Zhang Weidong and Zhao Limin, with Non-Executive Directors Zeng Tianming and Zhang Zhongmin. Independent Non-Executive Directors include Lu Zhengfei, Lam Chi Kuen, Wang Changyun, Sun Maosong, and Shi Cuijun. The Board oversees five committees, each led by various members, focusing on strategic development, audit, risk management, nomination and remuneration, and connected transactions.

China Cinda Asset Management Files Director List with HKEX

China Cinda Asset Management Co. Ltd. announced the resignation of Mr. Chen Xiaowu as non-executive director, effective December 31, 2025. He also held positions as chairman of the Risk Management Committee and member of the Strategic Development Committee and Nomination and Remuneration Committee.

China Cinda Asset Management Non-Executive Director Chen Xiaowu Resigns

China Cinda Asset Management Co. Ltd. has scheduled its first extraordinary shareholders’ meeting for 2026 on January 21, 2026, in Beijing. Shareholders will vote on the re-election of Mr. Wang Changyun and Mr. Sun Maosong as independent non-executive directors, and the election of Mr. Wang Pengcheng as an independent non-executive director.

China Cinda Asset Management Co. Ltd. Announces Date for 2026 First Extraordinary Shareholders' Meeting

06138

Harbin Bank Co. Ltd. has signed a loan transfer agreement with China Cinda Asset Management Co., Ltd. Tianjin Branch on December 29, 2025. The agreement involves the transfer of a specified loan to optimize Harbin Bank's asset structure. This transaction is classified as a discloseable transaction under Hong Kong Listing Rules, necessitating public reporting and announcement.

HARBIN BANK

Harbin Bank Sells Loan to China Cinda Asset Management

MBCINDA@EC2612A(23945.HK)

Luye Pharma Injects RMB285 Million into Nanjing Unit via Structured Deal

Cinda International Expects 2025 Net Profit to Surge to HK$74–82 Million

Zhongchang International Appoints Wu Hao as Executive Director

China Cinda Asset Management Co. Ltd. held extraordinary shareholders' meeting

CNEC: CHINA CINDA will reduce its holdings of the company's shares by 7.8666 million shares through centralized bidding from January 7, 2026, to January 9, 2026, accounting for approximately 0.26% of the total shares of the company